Načítá se...
Desialylation of dying cells with catalytically active antibodies possessing sialidase activity facilitate their clearance by human macrophages
Recently we reported the first known incidence of antibodies possessing catalytic sialidase activity (sialidase abzymes) in the serum of patients with multiple myeloma and systemic lupus erythematosus (SLE). These antibodies desialylate biomolecules, such as glycoproteins, gangliosides and red blood...
Uloženo v:
| Vydáno v: | Clin Exp Immunol |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Science Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4260892/ https://ncbi.nlm.nih.gov/pubmed/24580640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12312 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|